Fetma göder läkemedelsbolagen

from Börslunch · host EFN Ekonomikanalen

Börslunch tar sig i detta avsnitt an läkemedelssektorn. Tillsammans med gästerna Ellinor Hult, Health Invest och Johan Unnerus, Redeye analyseras Novo Nordisk, Bioarctic, Xvivo Perfusion, Calliditas, Camurus och Fusion Pharmaceuticals.

What this episode covers

NOW PLAYING

0:00 23:43

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Börslunch?

This episode is 23 minutes long.

When was this Börslunch episode published?

This episode was published on March 18, 2024.

What is this episode about?

Can I download this Börslunch episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!